GPT and metabolic dysfunction-associated steatotic liver disease: An adverse metabolic profile associated with hyperandrogenemia has been correlated to NAFLD in PCOS [20], however whilst all treatments reduced the FAI there was no correlation to changes in ALT, suggesting a hepatic dependent mechanism, and suggesting that the changes seen for rimonabant were independent of its affect on androgen reduction.